These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24714297)

  • 1. Patients with refractory gastroesophageal reflux disease: diagnostic tools.
    Karamanolis GP; Sifrim D
    Ann Gastroenterol; 2013; 26(1):6-10. PubMed ID: 24714297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
    Jain M; Agrawal V
    Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
    Frazzoni M; Piccoli M; Conigliaro R; Manta R; Frazzoni L; Melotti G
    Surg Endosc; 2013 Aug; 27(8):2940-6. PubMed ID: 23436097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
    Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy.
    Cheng FK; Albert DM; Maydonovitch CL; Wong RK; Moawad FJ
    Clin Gastroenterol Hepatol; 2015 May; 13(5):867-73. PubMed ID: 25445765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy.
    Richter JE
    Gastroenterol Hepatol (N Y); 2014 Sep; 10(9):547-55. PubMed ID: 27551249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease.
    Zerbib F; Bredenoord AJ; Fass R; Kahrilas PJ; Roman S; Savarino E; Sifrim D; Vaezi M; Yadlapati R; Gyawali CP
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14075. PubMed ID: 33368919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
    Spechler SJ
    Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on Functional Heartburn: Expert Review.
    Fass R; Zerbib F; Gyawali CP
    Gastroenterology; 2020 Jun; 158(8):2286-2293. PubMed ID: 32017911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
    Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
    Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic options for patients with refractory GERD.
    Fornari F; Sifrim D
    Curr Gastroenterol Rep; 2008 Jun; 10(3):283-8. PubMed ID: 18625140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring.
    Wang F; Li P; Ji GZ; Miao L; Fan Z; You S; Pan X; Chen X
    Medicine (Baltimore); 2017 Feb; 96(5):e5906. PubMed ID: 28151867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.
    Cicala M; Emerenziani S; Guarino MP; Ribolsi M
    World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Refractory Gastroesophageal Reflux Disease.
    Patel A; Yadlapati R
    Gastroenterol Hepatol (N Y); 2021 Jul; 17(7):305-315. PubMed ID: 34602892
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.